Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan.

about

Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan.

Item

http://www.wikidata.org/entity/Q52732724

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Early prediction for over two ...... -institutional study in Japan.

@en

Early prediction for over two ...... -institutional study in Japan.

@nl

type

Item

label

Early prediction for over two ...... -institutional study in Japan.

@en

Early prediction for over two ...... -institutional study in Japan.

@nl

prefLabel

Early prediction for over two ...... -institutional study in Japan.

@en

Early prediction for over two ...... -institutional study in Japan.

@nl

P1476

Early prediction for over two ...... -institutional study in Japan.

@en

P2093

Junko Yasumura

http://www.w3.org/2001/XMLSchema#string

Masaki Shimizu

http://www.w3.org/2001/XMLSchema#string

Masato Yashiro

http://www.w3.org/2001/XMLSchema#string

Syuji Takei

http://www.w3.org/2001/XMLSchema#string

Tomohiro Kubota

http://www.w3.org/2001/XMLSchema#string

Toshitaka Kizawa

http://www.w3.org/2001/XMLSchema#string

Yasuo Nakagishi

http://www.w3.org/2001/XMLSchema#string

Yoshifumi Kawano

http://www.w3.org/2001/XMLSchema#string

Yuichi Yamasaki

http://www.w3.org/2001/XMLSchema#string

P2860

A commentary on TREAT: the trial of early aggressive drug therapy in juvenile idiopathic arthritis.

Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-co

Receiver operating characteristic (ROC) curve for medical researchers.

Treating rheumatoid arthritis to target: recommendations of an international task force.

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up

Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan.

Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.

Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14397595.2017.1415628

http://www.w3.org/2001/XMLSchema#string

P50

Hiroyuki Wakiguchi

P577

2018-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29293033

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis